International evidence-based guideline for the assessment ...

International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018 Publication approvalThe guideline recommendations on pages 16 to 34 of this document were approved by the Chief Executive Officer of the National Health and Medical Research Council (NHMRC) on 2 July 2018 under section 14A of the National Health and Medical Research Council Act 1992. In approving the guideline recommendations, NHMRC considers that they meet the NHMRC standard for clinical practice guidelines. This approval is valid for a period of five is satisfied that the guideline recommendations are systematically derived, based on the identification and synthesis of the best available scientific evidence, and developed for health professionals practising in an Australian health care publication reflects the views of the authors and not necessarily the views of the Australian guideline was authored by Helena Teede, Marie Misso, Michael Costello, Anuja Dokras, Joop Laven, Lisa Moran, Terhi Piltonen and Ro

1.7 Menopause life-stage 47 1.8 Cardiovascular disease 48 1.9 Gestational diabetes, impaired glucose tolerance and type 2 diabetes 50 1.10 Obstructive sleep apnea 53 1.11 Endometrial cancer 55 Chapter Two Prevalence, screening, diagnostic assessment and treatment of emotional wellbeing 57 2.1 Quality of life 58

Tags:

  Menopause

Information

Related search queries